ROY HENRY: Open Payments
NPI 1306559786 · CEDAR RAPIDS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$509 in 32 payments from 10 companies in 2025. Trend: 2023 $101 · 2024 $163 · 2025 $509
Food & beverage: $509
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $168 |
| Otsuka America Pharmaceutical, Inc. | 3 | $67 |
| Alkermes, Inc. | 3 | $59 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| Teva Pharmaceuticals USA, Inc. | 2 | $33 |
| Corium, LLC | 1 | $30 |
| Lundbeck LLC | 1 | $19 |
| Almatica Pharma LLC | 1 | $18 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
Products named: VRAYLAR, Auvelity, CAPLYTA, REXULTI, ARISTADA, AUSTEDO XR, Azstarys, ABILIFY ASIMTUFII.
Industry payments across IA — which companies pay providers there.
